Venus Remedies Ltd Hits Upper Circuit Limit Amid Strong Market Activity and Positive Momentum
Venus Remedies Ltd, a microcap in the Pharmaceuticals and Biotechnology sector, reached its upper circuit limit today, with a notable intraday high. The stock has shown consistent performance, gaining significantly over the past few days, despite a decline in investor participation. It is trading above key moving averages.
Venus Remedies Ltd, a microcap player in the Pharmaceuticals and Biotechnology sector, has made headlines today by hitting its upper circuit limit. The stock reached an intraday high of Rs 526.5, marking a significant 5% increase from its previous close. This surge comes as the company has demonstrated consistent performance, gaining 15.7% over the last three days.Today, Venus Remedies opened with a notable gap up of 4.67%, reflecting strong market activity. The total traded volume reached approximately 0.74058 lakh shares, contributing to a turnover of Rs 3.88 crore. The stock's performance has outpaced its sector by 4.98%, showcasing its resilience in a fluctuating market environment.
Additionally, Venus Remedies is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend. However, it is worth noting that investor participation has seen a decline, with delivery volume dropping by 82.73% compared to the 5-day average.
In summary, Venus Remedies Ltd's performance today highlights its strong market position and positive momentum, as evidenced by its recent price movements and trading metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
